[go: up one dir, main page]

PL2346823T3 - Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu - Google Patents

Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu

Info

Publication number
PL2346823T3
PL2346823T3 PL09792268T PL09792268T PL2346823T3 PL 2346823 T3 PL2346823 T3 PL 2346823T3 PL 09792268 T PL09792268 T PL 09792268T PL 09792268 T PL09792268 T PL 09792268T PL 2346823 T3 PL2346823 T3 PL 2346823T3
Authority
PL
Poland
Prior art keywords
phenyl
decan
diaza
spiro
intermediates
Prior art date
Application number
PL09792268T
Other languages
English (en)
Inventor
George G Wu
Gerald Werne
Xiaoyong Fu
Robert K Orr
Frank Xing Chen
Jian Cui
Victoria M Sprague
Fucheng Zhang
Ji Xie
Liansheng Zeng
Louis Peter Castellanos
Yuyin Chen
Marc Poirier
Ingrid Mergelsberg
Original Assignee
Opko Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opko Health Inc filed Critical Opko Health Inc
Publication of PL2346823T3 publication Critical patent/PL2346823T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/46Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/2672-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
PL09792268T 2008-09-05 2009-09-04 Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu PL2346823T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9447408P 2008-09-05 2008-09-05
EP09792268.6A EP2346823B1 (en) 2008-09-05 2009-09-04 Intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
PCT/US2009/056020 WO2010028232A1 (en) 2008-09-05 2009-09-04 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds

Publications (1)

Publication Number Publication Date
PL2346823T3 true PL2346823T3 (pl) 2016-01-29

Family

ID=41402490

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09792268T PL2346823T3 (pl) 2008-09-05 2009-09-04 Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu

Country Status (13)

Country Link
US (2) US9249144B2 (pl)
EP (2) EP3034493A1 (pl)
JP (2) JP5736313B2 (pl)
KR (1) KR101719004B1 (pl)
CN (2) CN102203062B (pl)
AU (1) AU2009289598B2 (pl)
CA (1) CA2736195C (pl)
ES (1) ES2552322T3 (pl)
HU (1) HUE026148T2 (pl)
MX (1) MX2011002475A (pl)
PL (1) PL2346823T3 (pl)
PT (1) PT2346823E (pl)
WO (1) WO2010028232A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2584838T3 (es) 2006-04-05 2016-09-29 Opko Health, Inc Sal clorhidrato de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-espiro[4.5]decán-2-ona y procedimiento de preparación de la misma
ES2553805T3 (es) 2006-04-05 2015-12-11 Opko Health, Inc. Formulaciones farmacéuticas que comprenden sales de (5S,8S)-8-[{(1R)-1-(3,5-bis-(trifluorometil)fenil]-etoxi}-metil]-8-fenil-1,7-diazaespiro[4.5]decan-2-ona y su utilización médica
AR066191A1 (es) 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
AU2009289598B2 (en) 2008-09-05 2014-09-11 Opko Health, Inc. Process and intermediates for the synthesis of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
CN105503870A (zh) 2009-08-14 2016-04-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂
CN105017251B (zh) * 2015-06-30 2018-06-29 齐鲁制药有限公司 一种nk-1受体拮抗剂的制备方法及其中间体
EP3322422A1 (en) * 2015-07-15 2018-05-23 OPKO Health, Inc. Heteroaryl carbonitriles for the treatment of disease
CN106866669A (zh) * 2017-04-19 2017-06-20 成都百特万合医药科技有限公司 一种合成罗拉吡坦中间体的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010165A1 (en) 1992-10-28 1994-05-11 Merck Sharp & Dohme Limited 4-arylmethyloxymethyl piperidines as tachykinin antagonists
JPH08504435A (ja) 1992-12-14 1996-05-14 メルク シヤープ エンド ドーム リミテツド タキキニン受容体拮抗剤としての4−アミノメチル/チオメチル/スルホニルメチル−4−フェニルピペリジン
JPH09507500A (ja) 1994-01-13 1997-07-29 メルク シヤープ エンド ドーム リミテツド gem二置換アザシクロ系のタキキニン拮抗薬
GB9626746D0 (en) 1996-12-23 1997-02-12 Knoll Ag Process
JP2001523245A (ja) 1997-04-24 2001-11-20 メルク シヤープ エンド ドーム リミテツド 肥満を治療するためのnk−1受容体拮抗薬およびssriの使用
DE19815275B4 (de) 1998-04-06 2009-06-25 Evonik Degussa Gmbh Alkylidenkomplexe des Rutheniums mit N-heterozyklischen Carbenliganden und deren Verwendung als hochaktive, selektive Katalysatoren für die Olefin-Metathese
US6215019B1 (en) 1998-09-01 2001-04-10 Tilliechem, Inc. Synthesis of 5-decenyl acetate and other pheromone components
CN1213032C (zh) 1999-05-24 2005-08-03 加州理工学院 咪唑烷基金属卡宾易位催化剂
EP1237874B1 (en) 1999-12-17 2006-02-22 Schering Corporation Selective neurokinin antagonists
GB0004699D0 (en) * 2000-02-28 2000-04-19 Merck Sharp & Dohme Chemical synthesis
CA2419485C (en) 2000-08-10 2007-10-30 The Trustees Of Boston College Recyclable metathesis catalysts
US7122677B2 (en) * 2001-11-13 2006-10-17 Scherig Corporation NK1 antagonists
GB0129525D0 (en) 2001-12-10 2002-01-30 Floor Image Internat Ltd Improvements to floor posters
PE20030762A1 (es) 2001-12-18 2003-09-05 Schering Corp Compuestos heterociclicos como antagonistas nk1
PL199412B1 (pl) 2002-10-15 2008-09-30 Boehringer Ingelheim Int Nowe kompleksy rutenu jako (pre)katalizatory reakcji metatezy, pochodne 2-alkoksy-5-nitrostyrenu jako związki pośrednie i sposób ich wytwarzania
AR048526A1 (es) * 2004-04-07 2006-05-03 Schering Corp Antagonistas de nk1 de anillo de piperidina o pirrolidina fusionado, composiciones farmaceuticas que los comprenden y su uso en el tratamiento de enfermedades relacionadas con los receptores de neuroquinina nk1
EP2522664B1 (en) 2004-07-01 2017-04-12 OPKO Health, Inc. Piperidine derivatives as NK1 antagonists
JP4444745B2 (ja) 2004-07-08 2010-03-31 キヤノン株式会社 偏光分離素子および画像投射装置
US7354922B2 (en) * 2004-12-14 2008-04-08 Schering Corporation Bridged ring NK1 antagonists
TW200630380A (en) 2005-02-18 2006-09-01 Nat Univ Chung Hsing N-acylamino acid racemase of Deinococcus radiodurans and producing method thereof, and L-amino acid production method therefrom
EP2886549A1 (en) 2005-07-04 2015-06-24 Zannan Scitech Co., Ltd. Ruthenium complex ligand, ruthenium complex and the use of the complex as a catalyst in olefin metathesis reactions
ES2584838T3 (es) 2006-04-05 2016-09-29 Opko Health, Inc Sal clorhidrato de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-espiro[4.5]decán-2-ona y procedimiento de preparación de la misma
WO2007114922A2 (en) * 2006-04-05 2007-10-11 Schering Corporation Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
ES2553805T3 (es) 2006-04-05 2015-12-11 Opko Health, Inc. Formulaciones farmacéuticas que comprenden sales de (5S,8S)-8-[{(1R)-1-(3,5-bis-(trifluorometil)fenil]-etoxi}-metil]-8-fenil-1,7-diazaespiro[4.5]decan-2-ona y su utilización médica
AR066191A1 (es) * 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
PE20081891A1 (es) 2007-03-22 2008-12-27 Opko Health Inc Formulaciones de comprimidos que contienen sales de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-spiro[4.5]decan-2-ona y comprimidos elaborados a partir de estas
AU2009289598B2 (en) 2008-09-05 2014-09-11 Opko Health, Inc. Process and intermediates for the synthesis of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
CN105503870A (zh) 2009-08-14 2016-04-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂

Also Published As

Publication number Publication date
CA2736195A1 (en) 2010-03-11
JP2015143265A (ja) 2015-08-06
PT2346823E (pt) 2015-11-26
CN104496988A (zh) 2015-04-08
CN102203062B (zh) 2014-12-17
HUE026148T2 (en) 2016-05-30
AU2009289598A1 (en) 2010-03-11
MX2011002475A (es) 2011-08-03
KR101719004B1 (ko) 2017-03-22
CA2736195C (en) 2017-05-16
ES2552322T3 (es) 2015-11-27
CN102203062A (zh) 2011-09-28
AU2009289598B2 (en) 2014-09-11
US9249144B2 (en) 2016-02-02
US20160145256A1 (en) 2016-05-26
JP2012502053A (ja) 2012-01-26
US9822116B2 (en) 2017-11-21
WO2010028232A1 (en) 2010-03-11
HK1158623A1 (en) 2012-07-20
EP2346823A1 (en) 2011-07-27
CN104496988B (zh) 2017-04-12
EP3034493A1 (en) 2016-06-22
KR20110067117A (ko) 2011-06-21
US20140031549A1 (en) 2014-01-30
JP5736313B2 (ja) 2015-06-17
EP2346823B1 (en) 2015-08-19

Similar Documents

Publication Publication Date Title
PL2346823T3 (pl) Związki pośrednie w syntezie związków 8-[{1-(3,5-bis-(trifluorometylo)fenylo)etoksy}metylo]-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu
AP2011005706A0 (en) New compounds.
PT2365754T (pt) Composições herbicidas contendo compostos de benzoilpirazole
AU2008229327A8 (en) Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5- phenylimidazolone compounds as beta-secretase inhibitors
HUS1700037I1 (hu) A 8-[{1-(3,5-bisz-(trifluor-metil)-fenil)-etoxi}-metil]-8-fenil-1,7-diazaspiro[4.5]dekan-2-on hidroklorid sója, és eljárás elõállítására
IL211744A0 (en) New chemical compounds
SI2384326T1 (sl) Pirolo(2,3-d)pirimidinske spojine
ZA201008486B (en) 5-substituted isoindoline compounds
ZA201005097B (en) Herbicidal compounds
GB0800856D0 (en) Herbicidal compounds
GB0805318D0 (en) Herbicidal compounds
PL2380881T3 (pl) Nowy bicykliczny związek heterocykliczny
EP2344337A4 (en) FLUID EJECTION CARTRIDGE
PL2767366T3 (pl) Wkład paliwowy
IL201730A0 (en) Bridged six-membered ring compounds
ZA201102944B (en) Insulting cartridge
SI2266990T1 (sl) Spojina 3-fenilpirazolo(5,1-b)tiazola
IL211292A0 (en) Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates
IL205181A0 (en) Compounds for inhibiting ksp kinesin activity
IL213328A0 (en) Regeneration of 2,2'-cyclopropylidene-bis (oxazolines)
PL2280961T3 (pl) Związki 1,5-difenylo-pirolidyn-2-onu jako ligandy CB-1
GB0715206D0 (en) Catalyst compounds
GB0817604D0 (en) Low molecular weight, non-polar compound depleted media
HK1155152A (en) Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors
GB0805553D0 (en) Muz-v single shot cartridge converter